Management of Proteinuria at 22 Weeks in a 40-Year-Old Pregnant Woman
This patient requires immediate quantification of proteinuria with a spot urine protein-to-creatinine ratio (PCR), blood pressure monitoring, and close surveillance for preeclampsia development, as she is at particularly high risk given her age >35 years and the early gestational age at presentation.
Initial Diagnostic Approach
Confirm and Quantify Proteinuria
Obtain spot urine PCR immediately - this is the preferred test over 24-hour urine collection 1
- PCR ≥30 mg/mmol (0.3 mg/mg) confirms significant proteinuria
- If PCR >500 mg/mmol in a woman >35 years, this is associated with worse maternal outcomes 1
If dipstick was used for initial detection (≥1+), it must be confirmed with PCR 1
Reserve 24-hour urine collection only if nephrotic syndrome (>5 g/24h) is suspected, as this has implications for thromboprophylaxis 1
Assess Blood Pressure Rigorously
- Measure BP with validated automated device or liquid crystal sphygmomanometer 1
- If elevated (≥140/90 mmHg), repeat within hours to confirm
- If severe (≥160/110 mmHg), confirm within 15 minutes 1
- Consider 24-hour ambulatory BP monitoring or home BP monitoring to exclude white-coat hypertension 1
Determine Clinical Classification
At 22 weeks gestation, three diagnostic possibilities exist 1:
Gestational proteinuria - proteinuria without hypertension or other preeclampsia features
Chronic kidney disease - unmasked by pregnancy hyperfiltration
- Proteinuria before 20 weeks suggests pre-existing renal disease 3
- At exactly 22 weeks, this is a critical diagnostic window
Preeclampsia - if hypertension develops or other severe features present
Management Strategy
Enhanced Surveillance Protocol
Monitor more frequently than standard prenatal care for the remainder of pregnancy 1:
Weekly visits minimum with:
Laboratory monitoring every 1-2 weeks:
Fetal surveillance:
- Serial growth ultrasounds every 3-4 weeks
- Antenatal testing as indicated
Critical Age-Specific Consideration
This patient's age of 40 years places her at higher risk - a spot PCR >500 mg/mmol (versus >900 mg/mmol for younger women) is associated with worse maternal outcomes 1. Monitor particularly closely for:
- Development of hypertension
- Signs of end-organ damage (elevated liver enzymes, thrombocytopenia, rising creatinine)
- Fetal growth restriction
When to Escalate Care
Immediate senior clinical review required if 5:
- Hypertension develops (≥140/90 mmHg)
- Severe features appear: severe headache, visual changes, epigastric pain, oliguria, pulmonary edema
- Laboratory evidence of HELLP syndrome or renal dysfunction
- Fetal compromise (growth restriction, abnormal Doppler studies)
Delivery Timing
- Do NOT base delivery decisions on the degree of proteinuria alone 1, 6
- Management decisions should be guided by:
- Blood pressure control
- Presence of end-organ damage
- Evidence of declining GFR
- Fetal status
- Gestational age
Postpartum Follow-up
Assess proteinuria at 3 months postpartum 1:
- If proteinuria resolves: confirms gestational proteinuria
- If proteinuria persists: indicates underlying chronic kidney disease requiring nephrology referral
- This distinction is critical for counseling regarding future pregnancies
Common Pitfalls to Avoid
- Do not rely on dipstick alone - always confirm with PCR 1
- Do not assume this is benign isolated proteinuria - 51% of women with isolated proteinuria progress to preeclampsia, with higher rates when presenting <32 weeks 2
- Do not repeatedly measure proteinuria levels - this does not improve outcomes and may lead to unnecessary preterm deliveries 1, 4
- Do not dismiss normal BP - preeclampsia can develop later, and proteinuria may be the first sign 1, 2
- Do not forget postpartum assessment - persistent proteinuria indicates chronic kidney disease requiring long-term management 1